VBI Vaccines (VBIV)
(Delayed Data from NSDQ)
$0.09 USD
-0.02 (-18.97%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $0.08 -0.01 (-14.89%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For VBIV
-
VBI Vaccines Reports First Quarter 2024 Financial Results
-
VBI Vaccines Reports Third Quarter 2023 Financial Results
-
VBI Vaccines Reports Second Quarter 2023 Financial Results
-
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue Estimates
-
VBI Vaccines Reports First Quarter 2023 Financial Results
-
VBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Misses Revenue Estimates
-
VBI Vaccines, Inc. (VBIV) Reports Q3 Loss, Misses Revenue Estimates
-
VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
VBI Vaccines, Inc. (VBIV) Reports Q2 Loss, Misses Revenue Estimates
-
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates
-
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
-
VBI Vaccines, Inc. (VBIV) Reports Q3 Loss, Misses Revenue Estimates
-
Analysts Estimate VBI Vaccines, Inc. (VBIV) to Report a Decline in Earnings: What to Look Out for
-
VBI Vaccines, Inc. (VBIV) Reports Q2 Loss, Misses Revenue Estimates
-
Earnings Preview: VBI Vaccines, Inc. (VBIV) Q2 Earnings Expected to Decline
-
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates
-
Analysts Estimate VBI Vaccines, Inc. (VBIV) to Report a Decline in Earnings: What to Look Out for
-
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
-
VBI Vaccines, Inc. (VBIV) Reports Q2 Loss, Misses Revenue Estimates
-
VBI Vaccines (VBIV) to Report Q2 Earnings: What's in Store
-
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates
-
VBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Misses Revenue Estimates
-
Will VBI Vaccines, Inc. (VBIV) Report Negative Q4 Earnings? What You Should Know